On the other hand, interestingly, there appear to be a positive genetic interaction among PBRM1 and SETD2; a meta-analysis show that the frequency of SETD2 mutations in ccRCC is twice as high in tumors with PBRM1 mutations [100]. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.